Source:http://linkedlifedata.com/resource/pubmed/id/18457978
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0019704,
umls-concept:C0021311,
umls-concept:C0024432,
umls-concept:C0033268,
umls-concept:C0038952,
umls-concept:C0329040,
umls-concept:C0598312,
umls-concept:C0965144,
umls-concept:C1100939,
umls-concept:C1506764,
umls-concept:C1566354,
umls-concept:C1704256,
umls-concept:C1723137,
umls-concept:C1957815
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-6-2
|
pubmed:abstractText |
Monoxenic trypanosomatids, which usually are non-pathogenic in humans, have been detected in AIDS patients, but the mechanisms underlying the establishment of these protozoa in HIV-1-infected individuals are poorly understood. Here we addressed the role of HIV-1 and the HIV-1 Tat protein in the replication of the monoxenic trypanosomatid Blastocrithidia culicis in HIV-1-infected primary human macrophages. We found that HIV-1 and B. culicis replication augmented almost three times in co-infected macrophages, and that Tat antiserum significantly reduced the exacerbated protozoan growth. Exposure of B. culicis only infected macrophages to Tat protein also resulted in enhanced protozoan proliferation, reaching a twofold increase at 100 ng/mL. Electron microscopy analysis revealed that B. culicis and HIV-1 co-habit the same cells, and showed protozoan dividing forms inside macrophages. Protozoan replication diminished when B. culicis only infected macrophages were treated with Tat protein in the presence of anti-TGF-beta1 antibodies, suggesting a participation of this cytokine in the augmentation of protozoan multiplication. In fact, exogenous TGF-beta1 promoted the trypanosomatid replication in macrophages. Overall, our results suggest that HIV-1 infection deactivates the macrophage microbicidal activity, permitting the survival and multiplication of an otherwise non-pathogenic protozoan in these cells, a process partially mediated by Tat protein, via TGF-beta1 secretion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1286-4579
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
642-9
|
pubmed:dateRevised |
2008-12-30
|
pubmed:meshHeading |
pubmed-meshheading:18457978-Animals,
pubmed-meshheading:18457978-HIV Infections,
pubmed-meshheading:18457978-HIV-1,
pubmed-meshheading:18457978-Humans,
pubmed-meshheading:18457978-Macrophages,
pubmed-meshheading:18457978-Transforming Growth Factor beta1,
pubmed-meshheading:18457978-Trypanosomatina,
pubmed-meshheading:18457978-tat Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2008
|
pubmed:articleTitle |
HIV-1 infection and HIV-1 Tat protein permit the survival and replication of a non-pathogenic trypanosomatid in macrophages through TGF-beta1 production.
|
pubmed:affiliation |
Laboratório de Imunologia Clínica, Instituto Oswaldo Cruz/FIOCRUZ, RJ, Brazil.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|